SofWave Medical Ltd. (TLV:SOFW)
Israel · Delayed Price · Currency is ILS · Price in ILA 3,560.00
+92.00 (2.65%)
Oct 26, 2026, 5:24 PM IST
SofWave Medical Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 104.35 | 87.64 | 59.65 | 50.32 | 35.63 | 21.84 |
Revenue Growth | 50.17% | 46.92% | 18.55% | 41.22% | 63.15% | 408.95% |
Gross Profit Gross Profit Growth | 78.6 | 65.96 | 45.34 | 37.48 | 26.33 | 16.21 |
Operating Income Operating Income Growth | 10.13 | 6.87 | -3.58 | -7.99 | -17.34 | -9 |
Net Income Net Income Growth | 8.85 | 5.49 | -4.55 | -8.28 | -19.53 | -6.83 |
Earnings Per Share EPS Growth | 0.22 | 0.14 | -0.13 | -0.24 | -0.57 | -0.29 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
United States of America United States of America Growth | 50.85 | 45.64 | 33.59 | 29.59 | 20.69 | 13.45 |
Europe and The Middle East Europe and The Middle East Growth | 12.8 | 10.26 | 6.4 | 5.36 | 4.31 | 2.64 |
Southeast Asia Southeast Asia Growth | 36.18 | 28.51 | 16.88 | 12.61 | 9.46 | 5.75 |
Others Others Growth | 4.51 | 3.23 | 2.78 | 2.76 | 1.17 | - |
Total Total Growth | 104.35 | 87.64 | 59.65 | 50.32 | 35.63 | 21.84 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 38.31 | 34.75 | 21.62 | 24.42 | 32.01 | 46.22 |
Total Debt Total Debt Growth | 1.43 | 1.12 | 1.4 | 1.33 | 1.92 | 2.37 |
Net Cash (Debt) Net Cash Growth | 36.88 | 33.63 | 20.22 | 23.09 | 30.08 | 43.85 |
Net Cash Growth | 61.03% | 66.29% | -12.44% | -23.23% | -31.40% | 1607.59% |
Net Cash Per Share Net Cash Per Share Growth | 0.92 | 0.85 | 0.59 | 0.68 | 0.88 | 1.87 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 13.85 | 13.3 | -2.4 | -6.31 | -10.69 | -4.4 |
Capital Expenditures CapEx Growth | -0.78 | -0.53 | -0.28 | -0.41 | -0.45 | -0.82 |
Free Cash Flow Free Cash Flow Growth | 13.07 | 12.76 | -2.67 | -6.71 | -11.14 | -5.22 |
Free Cash Flow Growth | 402.58% | - | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 75.33% | 75.27% | 76.00% | 74.49% | 73.90% | 74.21% |
Operating Margin | 9.70% | 7.84% | -6.00% | -15.88% | -48.66% | -41.22% |
Pretax Margin | 8.82% | 6.55% | -6.80% | -16.42% | -53.91% | -32.73% |
Profit Margin | 8.48% | 6.26% | -7.62% | -16.45% | -54.81% | -31.26% |
FCF Margin | 12.53% | 14.56% | -4.48% | -13.34% | -31.27% | -23.90% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 54.41 | 56.34 | - | - | - | - |
P/FCF Ratio | 33.27 | 24.23 | - | - | - | - |
PS Ratio | 4.17 | 3.53 | 2.37 | 2.63 | 2.25 | 14.41 |